Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2018 | 4 |
2019 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Prospects for a MERS-CoV spike vaccine.
Expert Rev Vaccines. 2018 Aug;17(8):677-686. doi: 10.1080/14760584.2018.1506702. Epub 2018 Aug 9.
Expert Rev Vaccines. 2018.
PMID: 30058403
Free PMC article.
Review.
Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain.
Zhou Y, Yang Y, Huang J, Jiang S, Du L.
Zhou Y, et al.
Viruses. 2019 Jan 14;11(1):60. doi: 10.3390/v11010060.
Viruses. 2019.
PMID: 30646569
Free PMC article.
Review.
Item in Clipboard
Enhanced Ability of Oligomeric Nanobodies Targeting MERS Coronavirus Receptor-Binding Domain.
He L, Tai W, Li J, Chen Y, Gao Y, Li J, Sun S, Zhou Y, Du L, Zhao G.
He L, et al.
Viruses. 2019 Feb 19;11(2):166. doi: 10.3390/v11020166.
Viruses. 2019.
PMID: 30791410
Free PMC article.
Item in Clipboard
A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV.
Zhao G, He L, Sun S, Qiu H, Tai W, Chen J, Li J, Chen Y, Guo Y, Wang Y, Shang J, Ji K, Fan R, Du E, Jiang S, Li F, Du L, Zhou Y.
Zhao G, et al.
J Virol. 2018 Aug 29;92(18):e00837-18. doi: 10.1128/JVI.00837-18. Print 2018 Sep 15.
J Virol. 2018.
PMID: 29950421
Free PMC article.
Item in Clipboard
Lack of nervous necrosis virus (NNV) neutralizing antibodies in convalescent sevenband grouper Hyporthodus septemfasciatus after NNV infection.
Gye HJ, Oh MJ, Nishizawa T.
Gye HJ, et al.
Vaccine. 2018 Mar 27;36(14):1863-1870. doi: 10.1016/j.vaccine.2018.02.063. Epub 2018 Mar 2.
Vaccine. 2018.
PMID: 29503111
Item in Clipboard
Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection.
Wang Y, Tai W, Yang J, Zhao G, Sun S, Tseng CK, Jiang S, Zhou Y, Du L, Gao J.
Wang Y, et al.
Hum Vaccin Immunother. 2017 Jul 3;13(7):1615-1624. doi: 10.1080/21645515.2017.1296994. Epub 2017 Mar 9.
Hum Vaccin Immunother. 2017.
PMID: 28277821
Free PMC article.
Item in Clipboard
Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen.
Nyon MP, Du L, Tseng CK, Seid CA, Pollet J, Naceanceno KS, Agrawal A, Algaissi A, Peng BH, Tai W, Jiang S, Bottazzi ME, Strych U, Hotez PJ.
Nyon MP, et al.
Vaccine. 2018 Mar 27;36(14):1853-1862. doi: 10.1016/j.vaccine.2018.02.065. Epub 2018 Feb 26.
Vaccine. 2018.
PMID: 29496347
Free PMC article.
Item in Clipboard
Cite
Cite